These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16102852)

  • 1. Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
    Bastian FO; McDermott ME; Perry AS; Carver LA; Dash S; Garry RF
    J Virol Methods; 2005 Dec; 130(1-2):133-9. PubMed ID: 16102852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
    Minaki H; Sasaki K; Honda H; Iwaki T
    Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease (CJD) of a short duration with prion protein (PrP) plaques.
    Liberski PP; Kwieciński H; Barcikowska M; Mirecka B; Kulczycki J; Kida E; Brown P; Gajdusek DC
    Patol Pol; 1991; 42(4):115-8. PubMed ID: 1845486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review of Creutzfeldt-Jakob disease and other prion diseases].
    Zivkovic S; Boada M; López O
    Rev Neurol; 2000 Dec 16-31; 31(12):1171-9. PubMed ID: 11205554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Subtyping of PrP
    Klug GM; Lewis V; Collins SJ
    Methods Mol Biol; 2017; 1658():347-354. PubMed ID: 28861800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prion dementias: nosology and diagnostic difficulties in the spectrum of Creutzfeld-Jakob encephalopathy].
    Kálmán J; Járdánházy T; Cserháti A; Szekeres G; Demeter I; Berek I; Dobranovics I; Csernay L; Janka Z
    Orv Hetil; 1997 Mar; 138(12):731-7. PubMed ID: 9157343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment.
    Roeber S; Krebs B; Neumann M; Windl O; Zerr I; Grasbon-Frodl EM; Kretzschmar HA
    Acta Neuropathol; 2005 Apr; 109(4):443-8. PubMed ID: 15739100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
    Ritchie DL; Head MW; Ironside JW
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular typing of PrPres in human sporadic CJD brain tissue.
    Lewis V; Klug GM; Hill AF; Collins SJ
    Methods Mol Biol; 2008; 459():241-7. PubMed ID: 18576159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assessment of pathogenic prions in the brains of eye tissue donors: 2-years experience in the Czech Republic.
    Jirsova K; Krabcova I; Novakova J; Hnathova I; Koukolik F; Kubesova B; Netukova M; Matej R
    Cornea; 2010 Sep; 29(9):996-9. PubMed ID: 20520532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
    Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
    Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease: a protein disease.
    Knight R
    Proteomics; 2001 Jun; 1(6):763-6. PubMed ID: 11677782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.
    Kitamoto T; Shin RW; Doh-ura K; Tomokane N; Miyazono M; Muramoto T; Tateishi J
    Am J Pathol; 1992 Jun; 140(6):1285-94. PubMed ID: 1351366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.